$FRPT

Cyr William B. sold $3.1M of FRPT

Cyr William B. (Chief Executive Officer) sold 41,028 shares of Freshpet, Inc. (FRPT) at $74.80 ($3.07M total) on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cyr William B.
Published Aug 21, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FRPT
Bearish
medium confidence
Mentioned
$FRPT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRPTBearishLow
01

Why it matters

The sale reduces insider ownership, which could be viewed as a lack of confidence, potentially prompting short sellers.

02

Market read

Freshpet insider sale may influence short-term price action; broader market impact minimal.

03

What to watch

Sale executed via pre-arranged 10b5-1 plan, reducing negative interpretation.

Relevance 5/10Novelty 7/10Timing: filing date 2026-08-21

Background

Form 4 filing discloses insider transactions; Freshpet is a publicly traded pet food company.

Company-level read

Ticker impact

$FRPTBearishMedium confidence
Context

CEO Cyr William B. sold 41,028 shares for $3.07M via a 10b5-1 plan, reducing his stake to 288,493 shares.

Expected impact

Possible modest dip in FRPT price over next few days.

Evidence & confidence

Insider sales by CEOs often weigh on investor sentiment, especially when sizable relative to holdings.

Market effects

Pet food sector may see slight scrutiny on insider confidence.

U.S. market only; no broader regional effect.

Limited to Freshpet investors.

Counterpoint

Insider may be diversifying; sale does not reflect company fundamentals.

Key entities

  • Cyr William B.

    Chief Executive Officer of Freshpet, Inc.

  • Freshpet, Inc.

    Pet food manufacturer listed on NASDAQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRPTHighAI 9/10

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet (FRPT) reported Q2 2026 results ahead of its guidance range, with its strongest growth rate in over a year and highest adjusted gross margin since Q1 2020. The company raised 2026 sales and adjusted EBITDA guidance. It cited 41% digital order growth to 16.7% of sales, and expects 700 rural lifestyle retail stores by year-end.

$FRPTMed

Freshpet (FRPT) Is Up 12.4% After Raising 2026 Sales Outlook And Margins Improving - Has The Bull Case Changed?

Freshpet (FRPT) shares rose 12.4% after the company reported Q2 sales of $305.59 million and net income of $19.49 million, with improved year-to-date profitability and EPS. Freshpet said a shift toward loyal “MVP” households and higher adjusted gross margin supported lifting 2026 sales growth guidance to 10% to 12%, and it completed an $86.5 million share repurchase.

$FRPTHighAI 9/10

Freshpet CEO says company delivered its strongest growth rate in more than a year, as company announces 2nd quarter results

Freshpet reported Q2 2026 net sales up 15.5% to $305.6 million and gross profit of $128.7 million, 42.1% of sales. Net income rose to $19.5 million. CEO Billy Cyr cited stronger growth and highest adjusted gross margin since Q1 2020. The company updated 2026 guidance to 10% to 12% net sales growth and $210 million to $220 million adjusted EBITDA.

$FRPTHighAI 9/10

Why Are Freshpet (FRPT) Shares Soaring Today

Freshpet (FRPT) shares rose 12.7% after the company reported strong Q2 2026 results. Net sales were $305.6 million, up 15.5% year over year and above the $292.3 million consensus. EPS was $0.39 versus $0.22 expected. Adjusted EBITDA and a full-year adjusted EBITDA forecast midpoint of $215 million also beat estimates.

$FRPTMed

Freshpet Q2 Earnings Call Highlights

Freshpet (FRPT) said its low-end sales outlook assumes stable macro conditions, while hitting the high end would require stronger advertising, omnichannel gains, more distribution, faster category growth, and a return of trade-up. Q2 adjusted gross margin rose 170 bps to 48.6%. 2026 adjusted gross margin improvement guidance increased to 100 to 150 bps at the midpoint. Operating cash flow rose 31% to $44.4M; free cash flow was $14.7M.

$FRPTMedAI 8/10

Freshpet’s (NASDAQ:FRPT) Q2 CY2026: Strong Sales, Stock Soars

Freshpet (NASDAQ:FRPT) reported Q2 CY2026 results. Revenue rose 15.5% year on year to $305.6 million, exceeding Wall Street estimates by 4.5%, and GAAP profit was $0.39 per share, 73.6% above consensus. The article also cites analyst expectations for 7.1% revenue growth over the next 12 months and notes the stock rose 7.6% to $67.10 after the report.